May 31, 2020

Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study

Diabetologia
Bertrand CariouCORONADO investigators

Abstract

Coronavirus disease-2019 (COVID-19) is a life-threatening infection caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) virus. Diabetes has rapidly emerged as a major comorbidity for COVID-19 severity. However, the phenotypic characteristics of diabetes in COVID-19 patients are unknown. We conducted a nationwide multicentre observational study in people with diabetes hospitalised for COVID-19 in 53 French centres in the period 10-31 March 2020. The primary outcome combined tracheal intubation for mechanical ventilation and/or death within 7 days of admission. Age- and sex-adjusted multivariable logistic regressions were performed to assess the prognostic value of clinical and biological features with the endpoint. ORs are reported for a 1 SD increase after standardisation. The current analysis focused on 1317 participants: 64.9% men, mean age 69.8 ± 13.0 years, median BMI 28.4 (25th-75th percentile: 25.0-32.7) kg/m2; with a predominance of type 2 diabetes (88.5%). Microvascular and macrovascular diabetic complications were found in 46.8% and 40.8% of cases, respectively. The primary outcome was encountered in 29.0% (95% CI 26.6, 31.5) of participants, while 10.6% (9.0, 12.4) died and 18.0% (16.0, 20.2) we...Continue Reading

  • References
  • Citations1

References

  • We're still populating references for this paper, please check back later.
  • References
  • Citations1

Citations

  • This paper may not have been cited yet.

Mentioned in this Paper

Diabetes
Participant
Aspartate Aminotransferase Measurement
CD 2019
Body Mass Index
Coronaviridae
Life-threatening Infections
Observational Study
Health Center
REN

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Related Papers

Diabetic Medicine : a Journal of the British Diabetic Association
R C W Ma, R I G Holt
Journal of Diabetes
Zachary Bloomgarden
Thérapie
Béatrice BouhanickFrench Society of Pharmacology and Therapeutics (SFPT)
The Journal of Clinical Hypertension
Marijana TadicCarla Sala
© 2020 Meta ULC. All rights reserved